References
- 1. The Merk Manual, Twentieth Edition; 2018.
- 2. Postma DS, Bush A, vsn den Berger M. Risk factors and early origins of chronic obstructive pulmonary disease Lance; 2015.10.1016/S0140-6736(14)60446-3
- 3. WHO-Chronic Cor Pulmonale Report of an Expert Committee Circulation; 1963.
- 4. http://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed on 21 June 2021.
- 5. Duvoix A, Dickens J, Imram H, et. Al-Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. T thoarax; 2013.
- 6. Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease, Egyptian Journal of Chest Diseases and Tuberculosis; 2014.10.1016/j.ejcdt.2014.06.011
- 7. Bartolome RC, et al. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease, Am Journal Respir Crit Care Med; 2012.
- 8. Augusti A, Eduards LD, Rennards SI. Persistent systemic inflammation is associated with poor clinical outcomes in COPD- Biomarkers in clinical Practice; 2012.
- 9. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for The Diagnosis, Management and Prevention Of Chronic Obstructive Pulmonary Disease 2021 report.
- 10. Ulmeanu R, Mihălțan FD, Oancea C. Recomandări de diagnostic și tratament în Bronhopneumopatia Cronică Obstructivă [Diagnosis and Treatment Recommendations for Chronic Obstructive Brocnhopneumopathy], Medicala Publishing House; 2019.